Mannatt
Menu
  • Industries
    • Manatt Digital and Technology
    • Manatt Energy and Environmental
    • Manatt Entertainment
    • Manatt Financial Services
    • Manatt Health
    • Manatt Real Estate
    • Manatt Retail and Consumer Products
  • Services
    • Business Strategy and Consulting
      • Digital and Technology Consulting
      • Digital Health
      • Manatt Health
      • Manatt Housing Solutions
      • Manatt Real Estate Advisors
      • Manatt's Recovery Team
    • Corporate and Finance
      • Blockchain and Cryptocurrency
      • Cannabis and CBD
      • Capital Markets
      • Digital and Technology Transactions
      • Distressed Assets
      • Estate Planning and Personal Representation
      • Financial Services Transactions
      • Fintech
      • Games and Esports
      • Global Payments
      • Health Care Transactions
      • Manatt Leasing
      • Mergers and Acquisitions
      • Music
      • Private Equity and Buyout
      • Real Estate Transactions and Finance
      • Tax, Employee Benefits and Executive Compensation
      • Venture Capital / Emerging Companies
    • Government and Regulatory
      • Advertising, Marketing and Media
      • California State Government and Regulatory Policy and Government Contracts
      • Environment
      • Federal Government Affairs and Public Policy
      • Government Litigation and Administrative Law
      • Insurance
      • Investigations, Compliance and White Collar Defense
      • Land Use
      • Los Angeles Government and Land Use
      • Manatt Energy and Environmental
      • Manatt Health
      • Medical Technology and Life Sciences FDA Regulation
      • New York City Government, Policy and Government Contracts
      • New York State Government, Regulatory Policy and Government Contracts
    • Litigation
      • Advertising Litigation
      • Antitrust and Competition
      • Appellate
      • Bankruptcy
      • Capabilities to Serve Clients During COVID-19
      • Class Actions
      • Consumer Protection
      • Digital Media Litigation
      • Employment and Labor
      • Entertainment Litigation
      • Environmental Litigation
      • False Claims Act
      • Financial Services Litigation and Enforcement
      • Games and Esports
      • Government Litigation and Administrative Law
      • Health Care Litigation
      • Insurance
      • Intellectual Property Protection and Enforcement
      • Investigations, Compliance and White Collar Defense
      • Music
      • Privacy and Data Security
      • Real Estate Litigation
      • TCPA Compliance and Class Action Defense
      • Trademark and Copyright Litigation
      • Unmanned Aircraft
  • People
  • COVID-19
    • Navigating COVID-19: Issues Checklist
    • COVID-19 Guidance and Information
    • Manatt COVID-19 Client Service Response Team
    • Manatt Health COVID-19 Response
    • Capabilities to Serve Clients During COVID-19
    • California Government Resource Center
    • New York State Government Resource Center
  • Insights
    • News
    • Articles
    • Webinars
    • Podcasts
    • Events and Engagements
    • Newsletters
    • White Papers
  • Hot Topics
    • Children's Health
    • Election 2020
    • COVID-19
    • California's Privacy Legislation
    • Medicaid Managed Care
    • The Opioid Epidemic
  • About Us
    • About Manatt
    • Contact Us
    • Management
    • Diversity
    • Women's Initiative
    • Pro Bono
    • Global Network
    • Capabilities to Serve Clients During COVID-19
    • Insights@ManattHealth
  • Client Login
  • Careers
  • Offices
  • Insights
    @ManattHealth
Mannatt
  • Industries
    • Manatt Digital and Technology
    • Manatt Energy and Environmental
    • Manatt Entertainment
    • Manatt Financial Services
    • Manatt Health
    • Manatt Real Estate
    • Manatt Retail and Consumer Products
  • Services
    • Business Strategy and Consulting
      • Digital and Technology Consulting
      • Digital Health
      • Manatt Health
      • Manatt Housing Solutions
      • Manatt Real Estate Advisors
      • Manatt's Recovery Team
    • Corporate and Finance
      • Blockchain and Cryptocurrency
      • Cannabis and CBD
      • Capital Markets
      • Digital and Technology Transactions
      • Distressed Assets
      • Estate Planning and Personal Representation
      • Financial Services Transactions
      • Fintech
      • Games and Esports
      • Global Payments
      • Health Care Transactions
      • Manatt Leasing
      • Mergers and Acquisitions
      • Music
      • Private Equity and Buyout
      • Real Estate Transactions and Finance
      • Tax, Employee Benefits and Executive Compensation
      • Venture Capital / Emerging Companies
    • Government and Regulatory
      • Advertising, Marketing and Media
      • California State Government and Regulatory Policy and Government Contracts
      • Environment
      • Federal Government Affairs and Public Policy
      • Government Litigation and Administrative Law
      • Insurance
      • Investigations, Compliance and White Collar Defense
      • Land Use
      • Los Angeles Government and Land Use
      • Manatt Energy and Environmental
      • Manatt Health
      • Medical Technology and Life Sciences FDA Regulation
      • New York City Government, Policy and Government Contracts
      • New York State Government, Regulatory Policy and Government Contracts
    • Litigation
      • Advertising Litigation
      • Antitrust and Competition
      • Appellate
      • Bankruptcy
      • Capabilities to Serve Clients During COVID-19
      • Class Actions
      • Consumer Protection
      • Digital Media Litigation
      • Employment and Labor
      • Entertainment Litigation
      • Environmental Litigation
      • False Claims Act
      • Financial Services Litigation and Enforcement
      • Games and Esports
      • Government Litigation and Administrative Law
      • Health Care Litigation
      • Insurance
      • Intellectual Property Protection and Enforcement
      • Investigations, Compliance and White Collar Defense
      • Music
      • Privacy and Data Security
      • Real Estate Litigation
      • TCPA Compliance and Class Action Defense
      • Trademark and Copyright Litigation
      • Unmanned Aircraft
  • People
  • COVID-19
    • Navigating COVID-19: Issues Checklist
    • COVID-19 Guidance and Information
    • Manatt COVID-19 Client Service Response Team
    • Manatt Health COVID-19 Response
    • Capabilities to Serve Clients During COVID-19
    • California Government Resource Center
    • New York State Government Resource Center
  • Insights
    • News
    • Articles
    • Webinars
    • Podcasts
    • Events and Engagements
    • Newsletters
    • White Papers
  • Hot Topics
    • Children's Health
    • Election 2020
    • COVID-19
    • California's Privacy Legislation
    • Medicaid Managed Care
    • The Opioid Epidemic
  • About Us
    • About Manatt
    • Contact Us
    • Management
    • Diversity
    • Women's Initiative
    • Pro Bono
    • Global Network
    • Capabilities to Serve Clients During COVID-19
    • Insights@ManattHealth
  • Client Login
  • Careers
  • Offices
  • Insights
    @ManattHealth
  • Home
  • People
  • Joel S. Ario
Language:
  • English
    • English
    • Spanish
    • Portuguese
Share:

Joel S. Ario

Ario_Joseph_New-Bio-Template-730-x-730

Managing Director

Manatt Health
Contact
  • jario@manatt.com
  • Phone: 518.431.6719
  • Phone: 212.790.4588
  • Phone: 202.585.6500
  • Download vCard
  • Albany
  • New York
  • Washington, D.C.
Bar Admissions
Education
  • Harvard Law School, J.D., cum laude, 1981

    Harvard Divinity School, M.Div., cum laude, 1978

    Saint Olaf College, B.A., American Political Experience, 1975
    Phi Beta Kappa

Services
  • Insurance
Industries
  • Manatt Health

Show Full Bio

  • Profile
  • Speaking Engagements
  • Honors & Awards
  • Publications
Profile

Profile

With 30 years of experience shaping and implementing public health policy at the state and federal levels, Joel Ario provides strategic consulting and analysis on health care policies and institutions, with an emphasis on the evolving role of health insurers in delivering public and commercial coverage under various regulatory frameworks. He represents state governments, health plans, hospitals, foundations and other entities.

Joel's experience includes two decades of leading health insurance reform efforts for state and federal governments. As director of the Office of Health Insurance Exchanges at the U.S. Department of Health & Human Services, he worked closely with states and other stakeholders to develop the regulatory framework for exchanges, including the rights and responsibilities of states and the federal government in expanding coverage.

On the state level, Joel served as Pennsylvania Insurance Commissioner and Oregon Insurance Commissioner. He also served on the executive committee of the National Association of Insurance Commissioners and was an NAIC officer.

A well-known speaker on health care reform, Joel serves as an advisor to the Robert Wood Johnson Foundation in support of its work with states and has written extensively on how the ACA has impacted health insurance markets. Joel is based in Manatt's Albany office.

Speaking Engagements

Speaking Engagements

Panelist, “Insights into Insurance: Your Private Health Coverage Crash Course,” National Conference of State Legislatures, February 19, 2021.

Speaker, “The Next Generation of State Healthcare Cost Benchmarking,” National Association of Health Data Organizations 2020 Conference, August 25, 2020.

Moderator, “COVID-19 Health Data Users Group,” National Association of Health Data Organizations (NAHDO) and Mathematica, May 27, 2020.

Speaker, “Saving American Health Insurance in a Pandemic,” University of Minnesota, Center for Study of Politics and Governance and Humphrey School of Public Affairs, May 27, 2020.

Speaker, “Stabilizing and Strengthening the Affordable Care Act: States Forge Ahead,” AHIP’s 2020 National on the Individual and Small Group Markets, March 19, 2020. *Event canceled due to COVID-19

Panelist, “10 Years of the Affordable Care Act: What Now?” 26th Annual Wharton Health Care Business Conference, February 14, 2020.

Moderator, “2020 State Regulatory Agendas: Conversation With State Insurance Regulators,” American Medical Association State Advocacy Summit, January 10, 2020.

Panelist, “Hot Topic: National Roadmap on State-Level Efforts to End The Opioid Epidemic,” American Medical Association State Advocacy Summit, January 10, 2020.

Speaker, “Mental Health and Substance Use Disorder Parity: Today’s needs and tomorrow’s opportunities,” National Association of Insurance Commissioners Fall 2019 National Meeting, Austin, TX, December 9, 2019.

Panelist, “The Goals of Health Care Reform,” The Affordable Care Act at 10, New Haven, CT, September 27, 2019.

Panelist, “National Roadmap on State-Level Efforts to End the Opioid Epidemic: Leading-edge Practices and Next Steps,” American Medical Association Special Briefing, September 9, 2019.

Panelist, “Healthcare Reform Dynamics at the State Level,” Council of State Governments Bowhay Institute for Legislative Leader Development, Minneapolis, MN, August 12, 2019.

Speaker, “Ending the Opioid Epidemic: Leading-Edge Responses and Next Steps,” Regulatory Framework Task Force, NAIC Spring Meeting, April 6, 2019.

Moderator, “The Leadership of Regulators in Addressing the Opioid Epidemic,” American Medical Association State Advocacy Summit, January 11, 2019.

Moderator, “A Conversation With State Regulators: Protecting Patients in a Changing Regulatory Environment,” American Medical Association State Advocacy Summit, January 11, 2019.

Speaker, “Public and Private Solutions to Barriers in Health Care Transparency,” National Association of Health Data Organizations Health Care Data Summit 2018, Park City, Utah, Oct. 10, 2018.

Speaker, “Panel Discussion on State Options Regarding Section 1332 Waivers,” Health Care Reform Regulatory Alternatives Working Group, National Association of Insurance Commissioners Summer National Meeting, Boston, MA, Aug. 4.

Panelist, “Whiplash: The Affordable Care Act’s Twisted Path Through Implementation, Litigation, and Reinterpretation,” American Enterprise Institute, Washington, D.C., July 9.

Speaker, “Farewell Individual Mandate: How the New Individual Market Realities Will Affect Employers,” The ERISA Industry Committee, Washington, D.C., April 11, 2018.

Moderator, “A Conversation With State Regulators: What’s In Store For 2018?” American Medical Association’s 2018 State Legislative Strategy Conference, Fort Myers, FL, January 5, 2018.

Speaker, “State Options for Responding to Federal Changes to the Individual Market,” Robert Wood Johnson Foundation Webinar, January 4, 2018.

Panelist, “Regulation of the Nongroup Insurance Market,” ASLME and American University Washington College of Law’s Next Steps in Health Reform 2017 Conference, Washington, D.C., October 27, 2017.

Speaker, “Data and Methodological Challenges for §1332 Waiver Evaluations,” Robert Wood Johnson Foundation, Washington, D.C., October 17, 2017.

Speaker, “The Private Individual Insurance Market and the Use of Section 1332 to Provide Flexibility to States,” Bipartisan Policy Center Roundtable, Washington, D.C., September 14, 2017.

Panelist, “Healthcare Markets and Health Policy,” Council of State Governments’ BILLD Leadership Program, Minneapolis, MN, August 14, 2017.

Panelist, “Future of Healthcare: Stabilizing the Individual Insurance Market,” Bipartisan Policy Center Future of Healthcare Series, Washington, D.C., May 31, 2017.

Co-presenter, "Mapping the Healthcare M&A Landscape Under the New Administration," BNA webinar, April 27, 2017.

Speaker, “Insurance Exchanges: Status Report & Finance/Volume Implications,” The Governance Institute Leadership Conference, Scottsdale, AZ, April 24, 2017.

Panelist, “Protecting Consumers and Providers in Rapidly Consolidating Health Care Insurance and Provider Markets,” American Medical Association, 2017 State Legislative Strategy Conference, Amelia Island, FL, January 6, 2017.

Speaker, “Health Care Reform: New Directions in Washington and Minnesota Challenges,” Minnesota State Legislature, One Minnesota Legislative Conference, Minneapolis, MN, January 4, 2017.

Speaker, “Obamacare’s Administrative Law Space: Navigating the Next Frontier,” American Enterprise Institute, Expert Panel, Washington, D.C., December 12, 2016.

Speaker, “Transparency for Consumers and Regulators,” National Association of Insurance Commissioners, Fall National Meeting, December 11, 2016.

Speaker, “Update on the Exchanges,” U.S. Chamber of Commerce, Employee Benefits Committee, Washington, DC, September 28, 2016.

Co-presenter, “The Election’s Impact on Healthcare: Preparing for Potential Scenarios,” PharmaVOICE podcast, September 7, 2016.

Honors & Awards

Honors & Awards

CMS Award of Excellence, Center for Medicaid and Children’s Services, September 2011

Excellence in Consumer Advocacy Award, National Association of Insurance Commissioners (NAIC) Consumer Representatives, October 2010

Neil D. Levin Memorial Government Service Award, Israel Bonds, October 2009

Publications

Publications

Quoted, “Harm Reduction, Expanded Tx Access Included in White House Drug Policy Priorities,” MedPage Today, April 5, 2021.

Co-author, “State Public Options: Comparing Models from Across the Country,” California Health Care Foundation, March 12, 2021.

Co-author, “What’s Ahead for Health Policy in 2021,” RamaOnHealthcare, February 3, 2021.

Co-author, “Oregon Public Option Report: An Evaluation and Comparison of Proposed Delivery Models,” Oregon Health Authority, December 17, 2020.

Co-author, “Technology Opportunities for the ACA Marketplaces,” Robert Wood Johnson Foundation, December 15, 2020.

Co-author, “Stable Rates Reflect Strength of ACA Marketplaces,” Robert Wood Johnson Foundation’s State Health and Value Strategies program, October 30, 2020.

Co-author, “Updating the Essential Health Benefit Benchmark Plan: An Unexpected Path to Fill Coverage Gaps?” Robert Wood Johnson Foundation’s State Health and Value Strategies Program, September 11, 2020.

Co-author, "Planning Ahead To Address COVID-19 In The ACA’s 2021 Rate Review Process,” Health Affairs, May 10, 2020.

Co-author, “National Roadmap on State-Level Efforts to End the Opioid Epidemic: Leading-Edge Practices and Next Steps,” American Medical Association, September 9, 2019.

Co-author, “Strategies to Expand Transparency, Enhance Competition and Control Costs: A Toolkit for Insurance Regulators,” Robert Wood Johnson Foundation, July, 2019.

Co-author, “Spotlight on Mississippi: Best Practices and Next Steps in the Opioid Epidemic,” American Medical Association, May 8, 2019.

Co-author, “Spotlight on North Carolina: Best Practices and Next Steps in the Opioid Epidemic,” American Medical Association, May 8, 2019.

Co-author, “Spotlight on Colorado: Best Practices and Next Steps in the Opioid Epidemic,” American Medical Association, January 16, 2019.

Co-author, “Spotlight on Pennsylvania: Leading-Edge Practices and Next Steps in Ending the Opioid Epidemic,” American Medical Association, December 13, 2018

Co-author, “Enhancing the Value of Coverage Through Transparency: How APCDs Can Support Insurance Regulation,” Robert Wood Johnson Foundation, November 2018.

Co-author, “Transparency In Health Care: Where We Stand And What Policy Makers Can Do Now,” Health Affairs, July 11, 2018.

Co-author, “America’s Opioid Crisis,” Bloomberg BNA’s Pharmaceutical Law & Industry Report, March 30, 2018.

Co-author, “State Reinsurance Programs: Design, Funding, and 1332 Waiver Considerations for States,” Robert Wood Johnson Foundation’s State Health and Value Strategies program, March 2018.

Co-author, “State Marketplace Stabilization Strategies,” American Hospital Association, January 2018.

Co-author, “Building the Coverage Continuum: The Role of State Medicaid Directors and Insurance Commissioners,” The Commonwealth Fund, February 2017.

Author, “The ACA’s Section 1332 Waivers: Will We See More State Innovation in Health Care Reform?” NIHCM Foundation, August 2016.

Co-author, “Liberating Data to Enable Healthcare Market Transparency: A Guide for Regulators and Policymaker,” Novo Nordisk, March 2016.

Co-author, “How Mobile Apps will Empower Health Care Consumers,” Brookings, April 20, 2015.

Co-author, “Innovation Waivers: An Opportunity for States to Pursue Their Own Brand of Health Reform,” The Commonwealth Fund and the Robert Wood Johnson Foundation State Health Reform Assistance Network, April 2015.

“King v. Burwell: What a Subsidy Shutdown Could Mean for…Consumers, Insurers, Health Care Providers and States,” Series of four articles prepared for The Commonwealth Fund blog, February 24-27, 2015.

Co-author, “Reference Pricing And Network Adequacy Standards: Conflict Or Concord?” Health Affairs, September 18, 2014.

Co-author, “Understanding the Potential Role Web Brokers Can Play in State-Based Marketplaces,” Robert Wood Johnson Foundation’s State Health Reform Assistance Network, June 2014.

Co-author, “Premium Rate Variation In Exchanges Is An Eye Opener,” Health Affairs, August 7, 2013.

“Public Exchanges Dominate the Headlines, but Will Private Exchanges Really Shape the Future?” Manatt Health Update, June 24, 2013.

Co-author, “Post Election, The Affordable Care Act Leaves The Intensive Care Unit For Good,” Health Affairs, December 2012.

Co-author, “In the Wake of the Supreme Court Decision, Many Stakeholders Still Support the Affordable Care Act,” Health Affairs, August 2012.

Co-author, “Health Reform - Genie is Out of the Bottle,” The Hill, April 2012.

Joel in the News

  • 11.10.20

    Ario Discusses the Supreme Court’s Oral Arguments in the Affordable ...

    Manatt Health managing director Joel Ario spoke with Modern Healthcare and Insurance News Net about the Supreme Court’s pivotal ...

  • 05.04.20

    Manatt Expands Insurance Offerings With New Practice

    Manatt has expanded and formalized its insurance practice, which comprises a multidisciplinary team of professionals with significant ...

  • 03.26.20

    Ario Quoted in U.S. News & World Report on Health Insurance Amid ...

    Manatt Health managing director Joel Ario spoke with U.S. News & World Report about the importance of health insurance during the current ...

  • 11.12.19

    Ario Quoted in Health Plan Weekly on Georgia’s ACA Waiver Plan

    Manatt Health managing director Joel Ario spoke with Health Plan Weekly following Georgia’s draft waiver proposal that would drastically chan...

Show More

Joel's Articles

  • 04.14.21

    State Public Options: Comparing Models from Across the Country

    Nearly a dozen states have explored or are exploring the concept of a state-based public option or are actively pursuing some version of this ...



  • 12.17.20

    Oregon Public Option Report: An Evaluation and Comparison of Proposed ...

    Section 9 of Oregon State Senate Bill 770 (SB 770), signed into law in 2019, directed the state of Oregon to engage in an analysis to help ...



  • 12.16.20

    National Roadmap on State-Level Efforts to End the Nation's Drug ...

    Building on their 2019 “ National Roadmap on State-Level Efforts to End the Opioid Epidemic: Leading-Edge Practices and Next Steps,” the ...



  • 12.15.20

    Technology Opportunities for the ACA Marketplaces

    Technological innovation has always been at the center of the Affordable Care Act (ACA) Marketplaces and has never been more important than it is ...



Show More


Joel's Newsletters

  • 04.16.21

    National Roadmap on State-Level Efforts to End the Drug Overdose ...

    When we look at the progress made since our 2019 paper, we see that the results across states are mixed, with the COVID-19 pandemic creating new ...

  • 04.08.21

    State Public Options: State of Play and Potential for Future Action

    In recent years, state lawmakers have been considering and/or implementing policies to increase affordability for state consumers in the individual ...

  • 02.03.21

    What’s Ahead for Health Policy in 2021

    The Biden Administration is just two weeks old, and President Biden has already issued more than two dozen Executive Orders on racial justice, health ...

  • 11.09.20

    Election Update: What Are the Health Policy Implications?

    After a tumultuous four days, Joe Biden crossed the electoral college threshold to become the 46 th President of the United States, a result that ...

Show More


Joel's Events and Webinars

  • 11.17.20

    Post-Election: How Will the 2020 Election Results Impact Healthcare?

    Healthcare continues to be one of the key factors driving voters’ decisions in the upcoming elections. With the death of Supreme Court Justice ...



  • 10.28.20

    Pre-Election: How Will the 2020 Election Results Impact Healthcare?

    Discover How Federal and State Election Results Will Shape Healthcare Policies for Years to Come—and How You Can Prepare for What’s ...



  • 09.15.20

    State Strategies to Support Access to Substance Use Disorder ...

    Discover How States Are Coping With Substance Use Disorder Challenges Amid the COVID-19 Crisis at a New Manatt Webinar.  Prior to the ...



  • 04.23.20

    COVID-19: The Road Ahead for Commercial Health Insurance

    Examine the Evolving Challenges That Lie Ahead for Healthcare Stakeholders and State Regulators—and What You Can Do Now to Prepare and Protect ...



Show More
manatt-black

ATTORNEY ADVERTISING

pursuant to New York DR 2-101(f)

© 2021 Manatt, Phelps & Phillips, LLP.

All rights reserved 

 

  • Services
  • People
  • Insights
  • About Us
  • Careers
  • Offices & Contacts
  • Disclaimer
  • Privacy Statement

Share This Page

Your Information
Recipient's Information